"The National Institute on Minority Health and Health Disparities (NIMHD) part of the National Institutes of Health, has committed approximately $31 million over five years...to launch a new program for Transdisciplinary Collaborative Centers (TCCs) for health disparities research exploring the potential for precision medicine to promote health equity and advance the science of minority health and health disparities." - NIH News Release, July 28th, 2016
With the news of this funding venture comes additional pharmacogenomic-specific goals:
"Development of pharmacogenomic and other precision medicine tools to identify critical biomarkers for disease progression and drug responses in diverse populations,
Translation of pharmacogenomic discoveries into clinical practice including effective treatments."
Read more in the original press release below for more information on this exciting focus from the NIH in the field of personalized medicine.